Brinzolamide/TimololIn Open-Angle Glaucoma and Ocular Hypertension

被引：0
|
作者：
Jamie D. Croxtall
Lesley J. Scott
机构：
[1] Wolters Kluwer Health | Adis,
[2] Wolters Kluwer Health,undefined
来源：
Drugs & Aging | 2009年 / 26卷
关键词：
Glaucoma; Retinal Nerve Fibre Layer; Aqueous Humour; Timolol; Ocular Hypertension;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
▲ Brinzolamide 1%/timolol 0.5% fixed combination (brinzolamide/timolol) is a twice-daily eyedrops suspension comprising the carbonic anhydrase-II inhibitor brinzolamide and the β-adrenergic receptor antagonist timolol.
引用
收藏
页码：437 / 446
页数：9
相关论文
共 50 条
  • [31] Omidenepag isopropyl ophthalmic solution for open-angle glaucoma and ocular hypertension: an update
    Aihara, Makoto
    Aung, Tin
    Bacharach, Jason
    Cantor, Louis
    Kook, Michael
    Nakazawa, Toru
    Park, Ki Ho
    Lu, Da-Wen
    EXPERT REVIEW OF OPHTHALMOLOGY, 2021, 16 (04) : 243 - 250
  • [32] Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension
    Franks, Wendy
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (09) : 1643 - 1649
  • [33] Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension
    Radell, J. E.
    Serle, J. B.
    DRUGS OF TODAY, 2019, 55 (09) : 563 - 574
  • [34] Comparative Efficacy and Tolerability of Topical Prostaglandin Analogues for Primary Open-Angle Glaucoma and Ocular Hypertension
    Lin, Liang
    Zhao, Ying Jiao
    Chew, Paul T. K.
    Sng, Chelvin C. A.
    Wong, Hon-Tym
    Yip, Leonard W.
    Wu, Tuck Seng
    Bautista, Dianne
    Teng, Monica
    Khoo, Ai Leng
    Lim, Boon Peng
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (12) : 1585 - 1593
  • [35] Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension
    Netland, PA
    Robertson, SM
    Sullivan, EK
    Silver, L
    Bergamini, MVW
    Krueger, S
    Weiner, AL
    Davis, AA
    ADVANCES IN THERAPY, 2003, 20 (03) : 149 - 163
  • [36] Bimatoprost: An effective second-line option in the treatment open-angle glaucoma and ocular hypertension
    Drugs & Therapy Perspectives, 2003, 19 (8) : 1 - 4
  • [37] Tafluprost: The First Preservative-Free Prostaglandin to Treat Open-Angle Glaucoma and Ocular Hypertension
    Swymer, Cory
    Neville, Michael W.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1506 - 1510
  • [38] An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension
    Feldman, RM
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (04) : 909 - 921
  • [39] A comparative study on the efficacy of brinzolamide/timolol versus brinzolamide/brimonidine fixed drug combinations in primary open-angle glaucoma
    Padala, Sudeepthi
    Sripada, Ramam
    Gundabattula, Srivalli Bhaskari Padmavathi
    Tadi, Krishna Jyothi
    Nallamothula, Prabhakar Rao
    Raveshi, Farzaneh
    Magharla, Dasaratha Dhanaraju
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)
  • [40] Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension
    Iester, Michele
    CLINICAL OPHTHALMOLOGY, 2008, 2 (03): : 517 - 523
12345